🕵️ Heron Therapeutics, Inc. /DE/ ($HRTX)
SEC insider & ownership activity, last 12 months · CIK 818033 · every row links its SEC filing
Over the last 12 months insiders bought $8.7M with no open-market selling against it. Rubric Capital Management LP bought $5.0M in discretionary trades (Aug). Rubric Capital Management LP trimmed 17.5% → 15.9%; David Rosen trimmed 17.5% → 15.9%. One red-flag 8-K in the window: Delisting notice (3.01), Jun 25, 2026.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
2 buyers, $8.7M (5 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Rubric Capital Management LP | 3 | $5.0M | 0 | – | Aug 8, 2025 |
| Morgan Adam | 2 | $3.7M | 0 | – | Aug 8, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Rubric Capital Management LP | 15.9% | 13D | Oct 15, 2025 | filing ↗ | |
| David Rosen | 15.9% | 13D | Oct 15, 2025 | filing ↗ | |
| Clearline Capital LP | 6.7% | 13G | Feb 17, 2026 | filing ↗ | |
| Clearline Capital LLC | 6.7% | 13G | Feb 17, 2026 | filing ↗ | |
| Marc Majzner | 6.7% | 13G | Feb 17, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Delisting notice (3.01) | Jun 25, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 25, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 11, 2026 | filing ↗ |
| Other events (8.01) | Jun 2, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 2, 2026 | filing ↗ |
| Earnings (2.02) | May 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 11, 2026 | filing ↗ |
| Officer/director changes (5.02) | Apr 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 3, 2026 | filing ↗ |
| Earnings (2.02) | Feb 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 26, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 9, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 9, 2026 | filing ↗ |
| Earnings (2.02) | Nov 4, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 4, 2025 | filing ↗ |
| Officer/director changes (5.02) | Oct 27, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Oct 27, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 27, 2025 | filing ↗ |
| Shareholder vote (5.07) | Oct 15, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 15, 2025 | filing ↗ |
| Material agreement (1.01) | Aug 22, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 22, 2025 | filing ↗ |
| Material agreement (1.01) | Aug 13, 2025 | filing ↗ |
| Material Modifications to Rights of Security Holders (3.03) | Aug 13, 2025 | filing ↗ |
| Charter/bylaw changes (5.03) | Aug 13, 2025 | filing ↗ |
| Other events (8.01) | Aug 13, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 13, 2025 | filing ↗ |
| Material agreement (1.01) | Aug 8, 2025 | filing ↗ |
| Charter/bylaw changes (5.03) | Aug 8, 2025 | filing ↗ |
| Other events (8.01) | Aug 8, 2025 | filing ↗ |